FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
LOPERAMIDE HYDROCHLORIDE
loperamide hydrochloride
LOE Approaching
ORAL · CAPSULE
2005
NDA
30/100
LOPID
gemfibrozil
LOE Approaching
R-Pharm US
ORAL · TABLET
1981
NDA
30/100
LOPRESSOR
metoprolol fumarate
LOE Approaching
Novartis
ORAL · TABLET, EXTENDED RELEASE
1989
NDA
30/100
LOPRESSOR
metoprolol tartrate
LOE Approaching
Novartis
INJECTION · INJECTABLE
1984
NDA
30/100
LOPRESSOR
metoprolol tartrate
Launch
Rubicon Biotechnology
ORAL · SOLUTION
hypertension in adult patientsto lower blood pressure+7
2025
NDA
30/100
LOPRESSOR
metoprolol tartrate
LOE Approaching
Bausch Health
ORAL · TABLET
hypertension in adult patientsto lower blood pressure+7
1978
NDA
30/100
LOPRESSOR
metoprolol tartrate
Launch
ORAL · TABLET
the treatment of hemodynamically stable adult patients with myocardial infarctionto reduce the risk of cardiovascular mortality+1
2025
NDA
30/100
LOPRESSOR HCT
hydrochlorothiazide; metoprolol tartrate
LOE Approaching
Bausch Health
ORAL · TABLET
1984
NDA
30/100
LOPROX
ciclopirox
LOE Approaching
Eurofarma Laboratórios
TOPICAL · SUSPENSION
1988
NDA
30/100
LOPROX
ciclopirox
LOE Approaching
Eurofarma Laboratórios
TOPICAL · CREAM
1982
NDA
30/100
LOPROX
ciclopirox
LOE Approaching
Bausch + Lomb
TOPICAL · SHAMPOO
2003
NDA
30/100
LOPURIN
allopurinol
LOE Approaching
Abbott
ORAL · TABLET
1980
NDA
30/100
LORABID
loracarbef
LOE Approaching
Pfizer
ORAL · FOR SUSPENSION
1991
NDA
30/100
LORABID
loracarbef
LOE Approaching
Pfizer
ORAL · CAPSULE
1991
NDA
30/100
LORATADINE
loratadine
LOE Approaching
PharmaIN
ORAL · SUSPENSION
2005
NDA
30/100
LORATADINE
loratadine
LOE Approaching
Design Pharmaceuticals
ORAL · TABLET
2004
NDA
30/100
LORELCO
probucol
LOE Approaching
Sanofi
ORAL · TABLET
1977
NDA
30/100
LORFAN
levallorphan tartrate
LOE Approaching
Roche
INJECTION · INJECTABLE
1956
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
OPHTHALMIC · SUSPENSION/DROPS
1998
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
Bausch + Lomb
OPHTHALMIC · SUSPENSION/DROPS
steroid-responsive inflammatory conditions of the palpebralbulbar conjunctiva+11
1998
NDA
30/100
LOTEMAX
loteprednol etabonate
LOE Approaching
Bausch + Lomb
OPHTHALMIC · OINTMENT
post-operative inflammationpain following ocular surgery
2011
NDA
30/100
LOTEMAX
loteprednol etabonate
Peak
Bausch + Lomb
OPHTHALMIC · GEL
post-operative inflammationpain following ocular surgery+1
2012
NDA
30/100
LOTENSIN
benazepril hydrochloride
LOE Approaching
Bausch Health
ORAL · TABLET
hypertensionto lower blood pressure
1991
NDA
30/100
LOTENSIN HCT
benazepril hydrochloride and hydrochlorothiazide
LOE Approaching
Bausch Health
ORAL · TABLET
hypertension
1992
NDA
30/100
← PreviousPage 100 of 277Next →